ISS
ABCL icon

Intesa Sanpaolo SpA.’s AbCellera Biologics ABCL Stock Holding History

Intesa Sanpaolo SpA.’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$156K Sell
20,000
-144,371
-88% -$706K 0.01% 188
2026
Q1 		$567K Sell
164,371
-18,100
-10% -$65.1K 0.03% 129
2025
Q4 		$617K Buy
+182,471
New +$815K 0.04% 139

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Intesa Sanpaolo SpA.'s ABCL Position: Q2 2026 in Review

Intesa Sanpaolo SpA. reduced its AbCellera Biologics (ABCL) stake by 88% in Q2 2026, selling an estimated $706K and leaving 20,000 shares worth $156K. The position accounts for 0.01% of the portfolio, ranked #188.

Intesa Sanpaolo SpA. first reported a position in ABCL in Q4 2025 and has held it in 3 quarters since. The position peaked at $617K in Q4 2025. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Intesa Sanpaolo SpA. held 20,000 shares of AbCellera Biologics worth $156K as of Q2 2026.
  • Intesa Sanpaolo SpA. sold 144,371 AbCellera Biologics shares in Q2 2026, an estimated $706K.
  • AbCellera Biologics made up 0.01% of Intesa Sanpaolo SpA.'s portfolio in Q2 2026, its #188 holding.
  • Intesa Sanpaolo SpA. first reported a position in AbCellera Biologics in Q4 2025 and has held it in 3 quarters since.
  • Intesa Sanpaolo SpA.'s AbCellera Biologics position peaked at $617K in Q4 2025.
  • 151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Intesa Sanpaolo SpA.'s 13F filing for Q2 2026, filed 31 Jul 2026.